Month: March 2017

March 2, 2017
New human fibrinogen concentrate available

FibCLOT, a new human fibrinogen concentrate is now available in the UK, offering increased therapeutic choices for patients affected by congenital fibrinogen deficiency. FibCLOT, manufactured and marketed by LFB, is indicated for the treatment and perioperative prophylaxis of bleeding in patients with congenital hypo- or afibrinogenaemia with a tendency to bleed. A clinical study in children has …

Read article